Skip to content
10-Q

Quarterly Report

Pharma-Bio Serv, Inc. PBSV

0001654954-25-002888

← back to feed
Filed
Mar 17, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · Mar 12, 2025 22.93M sh
Current Liabilities Q1 2025 · Jan 31, 2025 $3.42M
Current Liabilities Q1 2025 · Oct 31, 2024 $1.89M
Total Liabilities Q1 2025 · Jan 31, 2025 $4.08M
Total Liabilities Q1 2025 · Oct 31, 2024 $2.58M
Current Assets Q1 2025 · Jan 31, 2025 $15.53M
Current Assets Q1 2025 · Oct 31, 2024 $15.7M
Total Assets Q1 2025 · Jan 31, 2025 $16.08M
Total Assets Q1 2025 · Oct 31, 2024 $16.29M
Shares Diluted Q1 2025 · Jan 31, 2024 22.99M sh
Stock Repurchased Q1 2025 · Jan 31, 2024 $7.19K
Capex Q1 2025 · Jan 31, 2024 $820
Operating Cash Flow Q1 2025 · Jan 31, 2024 $725.95K
Stockholders Equity Q1 2025 · Jan 31, 2024 $14.16M
Stockholders Equity Q1 2025 · Oct 31, 2023 $16.13M
Eps Diluted Q1 2025 · Jan 31, 2024 −$0.01
Sga Expense Q1 2025 · Jan 31, 2024 $973.91K
Net Income Q1 2025 · Jan 31, 2024 −$270.72K
Operating Income Q1 2025 · Jan 31, 2024 −$438.3K
Gross Profit Q1 2025 · Jan 31, 2024 $535.61K
Cost Of Revenue Q1 2025 · Jan 31, 2024 $1.84M
Revenue Q1 2025 · Jan 31, 2024 $2.38M